Systematic ReviewPublished 8 October 2026Selected traditional Chinese medicines for treating amyotrophic lateral sclerosis: a Bayesian network meta-analysis based on randomised controlled trialsChen Shen · Xiao-Ti Wu · Heng Yin · Jing-Ling Zuo · Chen-Hao Zhang · Feng Cao · Ying Zhang · Zi-Yu Tian · Nicola Robinson · Jian-Ping LiuFrontiers in Pharmacologydoi 10.3389/fphar.2026.1706211
Original ResearchPublished 23 July 2026ALS-associated FUS mutations induce site-specific alterations in conformational dynamics and molecular interactionsChristodoulos Amourgianos · Themis P. Exarchos · Panagiotis Vlamos · Marios G. KrokidisFrontiers in Chemical Biologydoi 10.3389/fchbi.2026.1851848
Original ResearchPublished 13 May 2026Peripheral immune cells and glycation indices as potential diagnostic biomarkers in amyotrophic lateral sclerosisXue Yang · Jing Yang · Rui Li · Hui Dong · Yaling LiuExperimental Biology and Medicinedoi 10.3389/ebm.2026.10987
Molecular MedicinePublished 13 February 2025Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosisD. Y. Mengistu · M. Terribili · C. Pellacani · L. Ciapponi · M. MarzulloFrontiers in Molecular Medicinedoi 10.3389/fmmed.2025.1530719
RNA ResearchPublished 18 September 2024Proteomic analysis of the SMN complex reveals conserved and etiologic connections to the proteostasis networkA. Gregory Matera · Rebecca E. Steiner · C. Allie Mills · Benjamin D. McMichael · Laura E. Herring · Eric L. GarciaFrontiers in RNA Researchdoi 10.3389/frnar.2024.1448194
NeurosciencePublished 1 May 2014Effectiveness of the P3-speller in brain–computer interfaces for amyotrophic lateral sclerosis patients: a systematic review and meta-analysisMauro Marchetti · Konstantinos PriftisFrontiers in Neuroengineeringdoi 10.3389/fneng.2014.00012
